Novartis India has agreed to acquire the Indian trademarks and related intellectual property for Pfizer's Minipress brand for ₹12.5 billion, or approximately $140 million, in a substantial addition to its portfolio of established medicines. Despite the Novartis name, the transaction is no longer an acquisition by Swiss pharmaceutical company Novartis AG....